enotalone logo Articles - Forum - Search - Home
eNotAlone > Health > Disorders and Diseases

Parkinson's Disease

8 Articles & Excerpts

Dopamine: Parkinson's Disease and ADHD to Smoking and Paranoia
by Joseph M. Carver, Ph.D.
Dopamine is a neurotransmitter linked to motor/movement disorders, ADHD, addictions, paranoia, and schizophrenia. Dopamine strongly influences both motor and thinking areas of the brain. One type of Dopamine works in the brain movement and motor system.

What Is Parkinson's Disease?
What Your Doctor May Not Tell You About Parkinson's Disease: A Holistic Program for Optimal Wellness
by Jill Marjama-Lyons, M.D., Mary J. Shomon
Parkinson's disease was first described in 1817 by James Parkinson, and the disease is named after him. In his classic essay The Shaking Palsy, he described the three most prominent features of Parkinson's disease

Treating Parkinson's Diseas, A Brain Pacemaker
by Food and Drug Administration (FDA)
The drug Dulaney took at the hospital, levodopa, is what doctors call the 'gold standard'; of Parkinson's therapy, because it is often the first-line treatment for the disease. Approved in 1970, levodopa helps restore muscle control when it is converted

Parkinson's Disease: Treatments
by Food and Drug Administration (FDA)
Though there still is no cure, Parkinson's patients have three new drugs and a medical device to help control this brain disease's devastating symptoms. Parkinson's disease is one of a larger group of neurological conditions called motor system disorders.

Parkinson's Diseas Surgery Options
by Food and Drug Administration (FDA)
A brain operation shown to be helpful for many Parkinson's patients, especially those in late stages of the disease, is called pallidotomy. Doctors are not sure why the procedure works, but an October 1997 report in the New England Journal of Medicine

Parkinson's Disease : Trying to Find the Cause
by Food and Drug Administration (FDA)
Parkinson's disease affects slightly more men than women and more whites than blacks in the United States. About three-quarters of all patients develop the disease between 50 and 65, though one person in seven develops it earlier, in the 30s or 40s.

Drugs Helping People with Parkinson's Disease
by Food and Drug Administration (FDA)
Combinations of drugs and modernization of old therapies are often improving the outlook for people suffering from this neurological ailment, while researchers continue to search for its cause.

Parkinson's Disease: More Than Just a Brain Disorder
by National Institute of Health
For many years, researchers have known that the movement problems associated with Parkinson's disease result from a loss of neurons that produce a nerve-signaling chemical called dopamine in one part of the brain.

   

© Copyright 2000-2006 eNotalone.com Inc. All rights reserved.